Related Experiment Video
Updated: Jun 23, 2026
10:59
Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
Integrative oncology in Australia.
1Department of Haematology/Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia. r.m.lowenthal@utas.edu.au
Journal of the Society for Integrative Oncology
|May 16, 2009
Summary
Complementary and alternative therapies for cancer are increasingly used in Australia. Government recommendations may lead to better quality controls, more information, and increased provision alongside conventional cancer care.
Area of Science:
- Oncology
- Integrative Medicine
- Public Health Policy
Background:
- Complementary and alternative therapies (CAT) are widely used by cancer patients in Australia.
- There is a growing trend in the utilization of these therapies among cancer patients.
- Current integration of CAT within Australian cancer centers is limited.
Purpose of the Study:
- To highlight the increasing use of CAT in Australian cancer care.
- To discuss government recommendations for improving CAT quality, information, and research.
- To anticipate the potential impact of policy changes on the provision of CAT in cancer centers.
Main Methods:
- This abstract is based on a review of recent government inquiries and policy recommendations.
- Analysis of current trends in complementary medicine use for cancer patients.
- Assessment of the potential future landscape of integrative oncology services.
Main Results:
- Government inquiries have recommended enhanced regulatory controls for complementary medicines.
- Recommendations include improving access to evidence-based information on CAT for cancer.
- Increased research into the efficacy of CAT for cancer is advised.
- Despite current limited provision, future policy adoption may drive integration and funding.
Conclusions:
- The increasing use of CAT in Australia necessitates attention to quality, evidence, and integration.
- Government policy shifts are anticipated to influence the availability and provision of CAT in cancer care.
- Future cancer care models in Australia may increasingly incorporate complementary therapies alongside conventional treatments.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...